Treatment results of radical radiotherapy of XXXX uterine cervix using external beam radiotherapy and high dose rate intracavitary radiotherapy.

@entity1 @entity66 @entity5 @entity189 @entity3831 @entity3
AIM: To report the outcome of @entity189 @entity1 treated radically by external beam radiotherapy and high dose rate intracavitary radiotherapy. MATERIAL AND METHODS: From January 2005 to December 2006, a total of 709 newly diagnosed cases of @entity189 were reported in our department. All cases were staged according to the International Federation of Gynecologist and Oncologist staging system. Out of 709 cases, 342 completed radical radiotherapy and were retrospectively analyzed for the presence of local @entity66 , local recurrence, distant @entity3 , radiation reaction, and disease free survival. RESULTS: There were 11(3.22%), 82(23.98%), 232(67.83%), and 17(4.97%) @entity1 in stages I, II, III, and IV, respectively. The median follow up time for all @entity1 was 36 months (range 3 -54 months). The overall treatment time (OTT) ranged from 52 to 69 days (median 58 days). The 3 year disease free survival rate was 81.8%, 70.7%, 40.08%, and 11.76% for stages I, II, III, and IV, respectively. There were 91 (26.6%) cases with local residual diseases, 27(7.9%) developed distant @entity3 , and 18(5.26%) pts had local recurrence. DISCUSSION: The results of this study suggest that radical radiotherapy with @entity3831 brachytherapy was appropriate for the treatment of early staged @entity5 . For locally advanced @entity5 of cervix addition of concurrent chemotherapy, higher radiation doses, reduction of overall treatment time to less than 8 weeks, and use of latest radiotherapy techniques such as IMRT is recommended to improve the results.
